Literature DB >> 10512151

Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH.

F Grossman1, W Z Potter.   

Abstract

Studies comparing urinary norepinephrine (NE) and its metabolites in unipolar or bipolar depressed patients and healthy volunteers have not yielded consistent findings. However, in unipolar depressed patients, most studies in non-elderly populations consistently report elevated concentrations of plasma NE, at least following an orthostatic challenge. Expanding upon previous studies which showed elevated plasma NE in depression, we compared the urinary excretion of NE, normetanephrine (NMN), 3-methoxy-4-hydroxyphenylglycol (MHPG), and vanillylmandelic acid (VMA) in age- and sex-matched unipolar and bipolar depressed patients versus healthy volunteers hospitalized at an inpatient unit at the National Institute of Mental Health. Only depressed subjects with a minimum 4-week drug-free period were included. Total turnover (NE + NMN + MHPG + VMA) was reduced in this sample of unipolar and bipolar depressed patients. MHPG concentration did not distinguish unipolar from bipolar depressed patients and was not significantly different from that in healthy volunteers. A construct of the average fractional extraneuronal concentration of NE (NE + NMN/NE + NMN + MHPG + VMA) was significantly higher in unipolar and bipolar depressed patients than in healthy volunteers. This finding extends data suggesting that unmedicated unipolar and bipolar depressed patients have a 'hyperresponsive' noradrenergic system and provides a framework which ties together plasma and urinary findings.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512151     DOI: 10.1016/s0165-1781(99)00055-4

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Association of depressive and anxiety symptoms with 24-hour urinary catecholamines in individuals with untreated high blood pressure.

Authors:  Nicola J Paine; Lana L Watkins; James A Blumenthal; Cynthia M Kuhn; Andrew Sherwood
Journal:  Psychosom Med       Date:  2015 Feb-Mar       Impact factor: 4.312

Review 2.  [Psychosomatic aspects of cardiac arrhythmias].

Authors:  Martin Siepmann; Wilhelm Kirch
Journal:  Med Klin (Munich)       Date:  2010-07-30

3.  Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment.

Authors:  A S Davison; B Norman; A M Milan; A T Hughes; M Khedr; J Rovensky; J A Gallagher; L R Ranganath
Journal:  JIMD Rep       Date:  2017-11-17

Review 4.  Impact of stress on cancer metastasis.

Authors:  Myrthala Moreno-Smith; Susan K Lutgendorf; Anil K Sood
Journal:  Future Oncol       Date:  2010-12       Impact factor: 3.404

5.  When is a phaeo not a phaeo? Depression in an adolescent leading to a phaeochromocytoma-like biochemical profile.

Authors:  Yonatan Yeshayahu; Susan Tallett; Karel Pacak; Claire De Souza; Mark R Palmert
Journal:  Clin Endocrinol (Oxf)       Date:  2011-10       Impact factor: 3.478

6.  Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients.

Authors:  Susan K Lutgendorf; Aliza Z Weinrib; Frank Penedo; Daniel Russell; Koen DeGeest; Erin S Costanzo; Patrick J Henderson; Sandra E Sephton; Nicolas Rohleder; Joseph A Lucci; Steven Cole; Anil K Sood; David M Lubaroff
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

Review 7.  Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers.

Authors:  Ather Muneer
Journal:  Psychiatry Investig       Date:  2015-11-20       Impact factor: 2.505

8.  Amphetamine increases activity but not exploration in humans and mice.

Authors:  Arpi Minassian; Jared W Young; Zackary A Cope; Brook L Henry; Mark A Geyer; William Perry
Journal:  Psychopharmacology (Berl)       Date:  2015-10-09       Impact factor: 4.530

9.  Differentiating Medicated Patients Suffering from Major Depressive Disorder from Healthy Controls by Spot Urine Measurement of Monoamines and Steroid Hormones.

Authors:  Chandra S Wijaya; Jovia J Z Lee; Syeda F Husain; Cyrus S H Ho; Roger S McIntyre; Wilson W Tam; Roger C M Ho
Journal:  Int J Environ Res Public Health       Date:  2018-04-26       Impact factor: 3.390

Review 10.  Integrated neurobiology of bipolar disorder.

Authors:  Vladimir Maletic; Charles Raison
Journal:  Front Psychiatry       Date:  2014-08-25       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.